| http://www.w3.org/ns/prov#value | - These T cells can become chronically overactivated, spurring a continuous attack by antibodies on the body's tissues.Current treatment strategies that inhibit cytokines, such as TNF or IL-1 production, spare the upstream initiating events that continuously induce new effector T cells and cytokine secretion, noted Cantor.
|